IRIS Accounts Production v23.2.0.158 10180706 Board of Directors 1.6.22 31.5.23 31.5.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh101807062022-05-31101807062023-05-31101807062022-06-012023-05-31101807062021-05-31101807062021-06-012022-05-31101807062022-05-3110180706ns10:Originalns15:EnglandWales2022-06-012023-05-3110180706ns14:PoundSterlingns10:Original2022-06-012023-05-3110180706ns10:Originalns10:Director12022-06-012023-05-3110180706ns10:Original2022-06-012023-05-3110180706ns10:Original2023-05-3110180706ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012023-05-3110180706ns10:Originalns10:SmallEntities2022-06-012023-05-3110180706ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012023-05-3110180706ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3110180706ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3110180706ns10:Originalns10:FullAccounts2022-06-012023-05-3110180706ns10:Originalns10:Director22022-06-012023-05-3110180706ns10:Originalns10:RegisteredOffice2022-06-012023-05-3110180706ns10:Original2022-05-3110180706ns10:Originalns5:CurrentFinancialInstruments2023-05-3110180706ns10:Originalns5:CurrentFinancialInstruments2022-05-3110180706ns5:ShareCapitalns10:Original2023-05-3110180706ns5:ShareCapitalns10:Original2022-05-3110180706ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3110180706ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3110180706ns10:Originalns5:ComputerEquipment2022-06-012023-05-3110180706ns10:Original2021-06-012022-05-3110180706ns10:Originalns5:ComputerEquipment2022-05-3110180706ns10:Originalns5:ComputerEquipment2023-05-3110180706ns10:Originalns5:ComputerEquipment2022-05-3110180706ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3110180706ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-31
REGISTERED NUMBER: 10180706 (England and Wales)















Unaudited Financial Statements

for the Year Ended 31 May 2023

for

Orange Health Limited

Orange Health Limited (Registered number: 10180706)






Contents of the Financial Statements
for the Year Ended 31 May 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Orange Health Limited

Company Information
for the Year Ended 31 May 2023







DIRECTORS: Ms V Tudyka
Ms L J Baker





REGISTERED OFFICE: 7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP





REGISTERED NUMBER: 10180706 (England and Wales)





ACCOUNTANTS: Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP

Orange Health Limited (Registered number: 10180706)

Balance Sheet
31 May 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 592 790

CURRENT ASSETS
Debtors 5 10,501 -
Cash at bank 515,503 495,577
526,004 495,577
CREDITORS
Amounts falling due within one
year

6

223,571

217,466
NET CURRENT ASSETS 302,433 278,111
TOTAL ASSETS LESS CURRENT
LIABILITIES

303,025

278,901

CAPITAL AND RESERVES
Called up share capital 102 102
Retained earnings 302,923 278,799
SHAREHOLDERS' FUNDS 303,025 278,901

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Orange Health Limited (Registered number: 10180706)

Balance Sheet - continued
31 May 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 January 2024 and were signed on its behalf by:





Ms V Tudyka - Director


Orange Health Limited (Registered number: 10180706)

Notes to the Financial Statements
for the Year Ended 31 May 2023

1. STATUTORY INFORMATION

Orange Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents trading income accrued during the period shown by these financial statements.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% Straight Line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Orange Health Limited (Registered number: 10180706)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipmen
£   
COST
At 1 June 2022
and 31 May 2023 1,857
DEPRECIATION
At 1 June 2022 1,067
Charge for year 198
At 31 May 2023 1,265
NET BOOK VALUE
At 31 May 2023 592
At 31 May 2022 790

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 10,501 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 25,722 61,018
Other creditors 197,849 156,448
223,571 217,466